UPDATED Jun 14, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$878.45 | 3.3% | 96.2% | US$795.4b | US$855.39 | PE128.9x | E27.3% | 0.6% | Pharmaceuticals & Biotech | ||
UNH | US$497.12 | 1.3% | 8.4% | US$457.7b | US$575.77 | PE29.8x | E19.7% | 1.5% | Healthcare | ||
JNJ | US$145.54 | -1.0% | -11.4% | US$350.1b | US$171.72 | PE20.5x | S4.4% | 3.4% | Pharmaceuticals & Biotech | ||
MRK | US$129.48 | -0.9% | 18.4% | US$327.7b | US$142.68 | PE142.2x | E23.7% | 2.4% | Pharmaceuticals & Biotech | ||
ABBV | US$168.59 | -0.5% | 21.6% | US$294.1b | US$183.04 | PE50x | E23.3% | 3.7% | Pharmaceuticals & Biotech | ||
TMO | US$572.05 | -1.6% | 6.5% | US$218.6b | US$629.47 | PE36.2x | E10.6% | 0.3% | Pharmaceuticals & Biotech | ||
DHR | US$254.85 | -3.1% | 5.4% | US$188.9b | US$273.31 | PE46.4x | E13.8% | 0.4% | Pharmaceuticals & Biotech | ||
ABT | US$103.68 | -3.6% | -2.4% | US$180.0b | US$125.37 | PE32.2x | E11.3% | 2.1% | Healthcare | ||
AMGN | US$298.62 | -2.1% | 30.0% | US$160.1b | US$316.44 | PE42.6x | E18.2% | 3.0% | Pharmaceuticals & Biotech | ||
PFE | US$27.53 | -3.7% | -31.3% | US$156.7b | US$31.92 | PS2.8x | E30.6% | 6.1% | Pharmaceuticals & Biotech | ||
ISRG | US$425.78 | 2.0% | 29.3% | US$150.0b | US$423.57 | PE76x | E11.7% | n/a | Healthcare | ||
SYK | US$344.98 | -1.2% | 17.2% | US$130.7b | US$372.50 | PE39.1x | E10.5% | 0.9% | Healthcare | ||
ELV | US$534.81 | -0.8% | 20.7% | US$125.2b | US$607.19 | PE19.9x | E12.2% | 1.2% | Healthcare | ||
VRTX | US$480.73 | -0.5% | 38.2% | US$123.6b | US$463.42 | PE30.9x | E10.4% | n/a | Pharmaceuticals & Biotech | ||
BSX | US$76.76 | -0.5% | 41.3% | US$113.1b | US$82.26 | PE63.9x | E18.2% | n/a | Healthcare | ||
REGN | US$1,036.52 | 3.3% | 32.4% | US$110.7b | US$1,047.30 | PE29x | E12.5% | n/a | Pharmaceuticals & Biotech | ||
MDT | US$81.04 | -3.6% | -9.1% | US$107.1b | US$94.07 | PE28.9x | E12.9% | 3.5% | Healthcare | ||
CI | US$333.29 | -1.4% | 24.0% | US$94.9b | US$392.04 | PE26.2x | E17.9% | 1.7% | Healthcare | ||
HCA | US$337.47 | 0.009% | 16.3% | US$89.3b | US$351.29 | PE16.2x | E6.0% | 0.8% | Healthcare | ||
BMY | US$41.20 | -0.7% | -37.7% | US$84.1b | US$53.19 | PS1.8x | E44.7% | 5.8% | Pharmaceuticals & Biotech | ||
GILD | US$65.06 | 0.6% | -17.5% | US$79.2b | US$82.70 | PE167.1x | E36.2% | 4.7% | Pharmaceuticals & Biotech | ||
ZTS | US$170.55 | -3.6% | -0.1% | US$78.2b | US$210.15 | PE32.5x | E8.6% | 1.0% | Pharmaceuticals & Biotech | ||
MCK | US$589.95 | 0.5% | 45.2% | US$76.8b | US$594.89 | PE25.5x | E9.6% | 0.4% | Healthcare | ||
CVS | US$60.22 | -2.5% | -11.1% | US$76.6b | US$69.02 | PE10.3x | E8.8% | 4.4% | Healthcare |